抗氧化纳米酶用于预防病变肾脏走向衰竭
Antioxidant nanozymes for prevention of diseased kidney from failure.
PubMed 文献 · Kidney Int · 2022-01-01
本文为评论文章,讨论抗氧化金铂纳米颗粒及其在已诊断慢性肾脏病患者中预防肾衰竭的潜力;天然抗氧化剂生物利用度低,限制其抗自由基疗效。
要点
- 氧化应激是自由基过多状态,常见于病变肾脏。
- 天然抗氧化剂生物利用度低,限制其抗自由基疗效。
- 评论讨论新型抗氧化金铂纳米颗粒预防慢性肾脏病患者肾衰竭的潜力。
核心结论
- 评论讨论新型抗氧化金铂纳米颗粒及其在已诊断慢性肾脏病患者中预防肾衰竭的潜力。
研究设计与样本
- 本文为评论文章,讨论抗氧化金铂纳米颗粒用于肾脏疾病管理的潜力。
主要发现
- 氧化应激是自由基过多状态,常见于病变肾脏。
- 天然抗氧化剂生物利用度低,限制其抗自由基疗效。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Oxidative stress is a state of excessive free radicals and is commonly found with diseased kidneys. Therefore, development of antioxidant-based therapy has been of great interest to biomedical scientists for kidney disease management. One of the drawbacks of using natural antioxidants is their low bioavailability, which limits their anti-free radical efficacy. This commentary discusses novel antioxidant gold-platinum nanoparticles and their potential for prevention of kidney failure in patients who are diagnosed with chronic kidney disease.
来源:Kidney Int,查看原文。版权归原作者所有。
引用
- Guan Q, Du C. Antioxidant nanozymes for prevention of diseased kidney from failure. Kidney Int. 2022. PMID: 36272752. doi:10.1016/j.kint.2022.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。